Juno Therapeutics Company
Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Total Funding:
310000000
Headquarters:
Seattle, Washington, United States
Funding Status:
M&A
Employee Number:
251-500
Estimated Revenue:
$100M to $500M
Last Funding Type:
Series B
Number Of Exists:
2
Last Funding Date:
2014-08-05
Investors Number:
4
Founded Date:
2013-01-01
Industry:
CAR-T